山东大学耳鼻喉眼学报 ›› 2017, Vol. 31 ›› Issue (3): 31-36.doi: 10.6040/j.issn.1673-3770.0.2017.174
接英,卢红双
JIE Ying, LU Hongshuang
摘要: 变应性结膜炎是临床上常见的眼部疾病,患病率高达15%~40%,包括季节性变应性结膜炎、常年性变应性结膜炎、春季卡他性角结膜炎、特应性角结膜炎以及巨乳头结膜炎等。变应性结膜炎可影响患者的生活质量,严重者甚至可能致盲。近年来,泪液细胞学检查和泪液特异性蛋白检测为变应性结膜炎的诊断提供了新的手段。新型免疫抑制剂滴眼液在重症变应性结膜炎治疗中取得良好效果,变应原特异性免疫治疗在季节性和常年变应性结膜炎治疗中有良好前景。
中图分类号:
| [1] La Rosa M, Lionetti E, Reibaldi M, et al. Allgergic conjunctivitis: a comprehensive review of the literature[J]. Ital J Pediatr, 2013, 39(1):18. [2] Rosario N, Bielory L. Epidemiology of allergic conjunctivitis[J]. Curr Opin AllergyClin Immunol, 2011, 11(15):471-476. [3] Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its impact on Asthma(ARIA)2008 update(in collaboration with the World Health Oraganization, GA(2)LEN and AllerGen)[J]. Allergy, 2008, 63(Suppl 86):8-160. [4] Wong AH, Barg SS, Leung AK. Seasonal and perennial conjunctivitis[J]. Recent Pat Inflamm Allergy Drug Discov, 2009, 3(2):118-127. [5] Butrus S, Portela R. Ocular allergy:diagnosis and treatment[J]. Ophthalmol Clin North Am, 2005,18(4):1019-1032. [6] La Rosa M, Lionetti E, Reibaldi M, et al. Alllergic conjunctivitis:a comprehensive review of the literature[J]. Ital J Pediatr, 2013, 39:18. [7] Leonardi A, De Dominicis C, Motterle L. Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities[J]. Curr Opin Allergy Clin Immunol, 2007, 7(5):429-435. [8] Kari O, Saari KM. Diagnostics and new developments in the treatment of ocular allergies[J]. Curr Allergy Asthma Rep, 2012, 12(3):232-239. [9] Leonardi A, Lazzarini D, Motterle L, et al. Vernal Keratoconjunctivitis-like disease in adults[J]. Am J Ophthalmol, 2013, 155(5):796-803. [10] Saboo US, Jain M, Reddy JC, et al. Demographic and clinical profile of vernal keratoconjunctivitis at a tertiary eye care centre[J]. Indian J Ophthalmol, 2013, 61(9):486-489. [11] Jun J, Bielory L, Raizman MB. Vernal conjunctivitis[J]. Immunol Allergy Clin North Am, 2008, 28(1):59-82. [12] Sangwan VS, Jain W, Vemuganti GK, et al. Vernal keratoconjunctivitis with limbal stem cell deficiency[J]. Cornea, 2011, 30(5):491-496. [13] Guglielmetti S, Dart JK, Calder V. Atopic keratoconjunctivitis and atopic dermatitis[J]. Curr Opin Allergy Clin Immunol, 2010, 10(5):478-485. [14] Bielory B, Bielory L. Atopic dermatitis and keratoconjunctivitis[J]. Immunol Allergy Clin North Am, 2010, 30(3):323-326. [15] Power WJ, Tugal-Tutkun I, Foster CS. Long-term follow-up of patients with atopic keratoconjunctivitis.[J]. Ophthalmol, 1998, 105(4):637-642. [16] Joseph J, Chen MD, Danielle S, et al. Atopic keratoconjunctivitis: A review[J]. J Am Acad Dermatol, 2014, 70(3):569-575. [17] Leonardi A. Allergy and allergic mediators in tears[J]. Exp Eye Res, 2013, 117:106-117. [18] Mimura T, Usui T, Yamagami S, et al. Relation between total tear Ig E and severity of acute seasonal allergic conjunctivitis[J]. Curr Eye Res, 2012, 37(10):864-870. [19] Mimura T, Yamagami S, Kamei Y, et al. Specific IgE in tear fluid and features of allergic conjuntivitis[J]. Curr Eye Res, 2013, 38(9):917-925. [20] Anderson DF, MacLeod JD, Baddeley SM, et al. Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration[J]. Clin Exp Allergy, 1997, 27(9):1060-1066 [21] Leonardi A, Palmigiano A, Mazzola EA, et al. Identification of human tear fluid biomarkers in vernal keratoconjunctivitis using iTRAQ quantitative proteomics[J]. Allergy, 2014, 69(2):254-260. [22] Pattnaik L, Acharya L. Acomprehensive review on vernal keratoconjunctivitis with emphasis on proteomics[J]. Life Sci, 2015, 128:47-54. [23] Fujishima H, Okada N, Matsumoto K, et al. The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases[J]. J Allergy Clin Immunol, 2016, 138(2):459-467. [24] OBrien TP1. Allergic conjunctivitis: an update on diagnosis and management[J]. Curr Opin Allergy Clin Immunol, 2013, 13(5):543-549. [25] Mahvan TD, Buckley WA, Hornecker JR. Alcaftadine for the Prevention of Itching Associated with Allergic Conjunctivitis[J]. Ann Pharmacother, 2012, 46(7-8):1025-1032. [26] Yaylali V, Demirlenk I, Tatlipinar S, et al. Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis[J]. Acta Ophthalmol Scand, 2003, 81(4):378-382. [27] Kari O, Saari KM. Updates in the treatment of ocular allergies[J]. J Asthma Allergy, 2010, 3:149-158. [28] Pacharn P, Vichyanond P. Immunomodulators for conjunctivitis[J]. Curr Opin Allergy Clin Immunol, 2013, 13(5):550-557. [29] Akpek EK, Dart JK, Watson S, et al. A randomized trial of topical cyclosporine 0.05% in topical steroid-resistant atopic keratoconjunctivitis[J]. Ophthalmol, 2004, 111(3):476-482. [30] Daniell M, Constantinou M, Vu HT, et al. Randomised contraolled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis[J]. Br J Ophthalmol, 2006, 90(4):461-464. [31] Virtanen HM, Reitamo S, Kari M, et al. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis:a retrospective study[J]. Acta Ophthalmol Scand, 2006, 84(5):693-695. [32] Labcharoenwongs P, Jirapongsananuruk O, Visitsunthom N, et al. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children[J]. Asian Pac J Allergy Immunol, 2012, 30(3):177-184. [33] Amin HS, Liss GM, Bernstein DI. Evaluation of near-fatal reactions to allergen immunotherapy injections[J]. J Allergy Clin Immunol, 2006, 117(1):169-175. [34] Vadlamudi A, Shaker M. New developments in allergen immunotherapy[J]. Curr Opin Pediatr, 2015, 27(5):649-655. [35] Calderon MA, Penagos M, Sheikh A, et al. Sublingual immunotherapy for treating allergic conjunctivitis[J]. Cochrane Database Syst Rev, 2011, 7: CD007685. doi: 10.1002/14651858.CD007685. pub2. |
| [1] | 方璐, 雷玉丹, 王华. 环孢素滴眼液联合玻璃酸钠滴眼液治疗干眼临床效果的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 65-73. |
| [2] | 雷玉丹,方璐,陈健,彭昌福. 托珠单抗治疗激素抵抗或不耐受的中重度甲状腺相关性眼病临床疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 54-67. |
| [3] | 朱明琼,李征,刘茹,田涛,彭婧利,吕倩怡,谭华霞. 基于OCT/OCTA的AI筛查系统在抗VEGF治疗糖尿病性黄斑水肿患者效果评价中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 68-73. |
| [4] | 卢朝阳, 翟兆雪, 王慧康, 邵丽婷, 张宇. 新冠肺炎治疗引发糖尿病酮症酸中毒合并鼻眶脑型毛霉菌病1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 90-94. |
| [5] | 顾敏,陆美萍. 纳米药物输送系统在变应性鼻炎过敏原免疫治疗中的应用进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 106-111. |
| [6] | 程卓, 梁辉, 邢鲁民. 深度学习技术在咽喉内镜应用中的研究进展及前景分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 112-119. |
| [7] | 刘一洁,卢秀珍,吴秋欣. 外泌体在眼病发病机制和诊疗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 135-141. |
| [8] | 马孝宝,沈佳丽,杨军,陈建勇,朱颂欢. 水平半规管扫视波的临床意义探究[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 40-45. |
| [9] | 刘梓琪,黄佳丽,汪李琴,陈曦,张立庆,周涵. 窄带成像内镜联合嗓音声学分析在声带白斑鉴别诊断中的价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 87-96. |
| [10] | 刘玉柱,陈尧,苑铁君,李春森,李波. 喉纤维肉瘤1例并相关文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 133-137. |
| [11] | 韩鑫宇,陈钢钢,李莹,周丽媛,杨捷,吴佳鑫,李育军. 双侧前庭病的非药物治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 154-159. |
| [12] | 王晓杰,张明君,宋哲莹,崔丽梅,宋西成. 山奈酚抗癌的作用机制及研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 168-178. |
| [13] | 刘南仙,杨泽垠,韩琳,张爱英,赵宇亮,薛静,孙怡君,邵永良. 视频脑电图在儿童复发性眩晕诊断中的意义[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 20-25. |
| [14] | 许雪萌,樊磊,喻望博,蒋芝月,潘晨,黄泳芹. 奥马珠单抗联合特异性免疫治疗变应性鼻炎疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 26-33. |
| [15] | 刘玉柱,苑铁君,李波. 会厌原发神经内分泌癌1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 97-100. |
|
||